Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 5/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.50 |
| ▸ | CHRND | Q07001 | 5/20 | 0.49 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.49 |
| ▸ | CHRNG | P07510 | 1/20 | 0.49 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.49 |
| ▸ | MME | P08473 | 1/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.49 |
| ▸ | CPA1 | P15085 | 1/20 | 0.49 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.49 |
| ▸ | PLG | P00747 | 1/20 | 0.48 |
| ▸ | PLAU | P00749 | 1/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28031750 | 1.00 | GRIA1 (0.50) | GRIA1FOLH1CHRNDCHRNA1CHRNG | |
| SCHEMBL620470 | 1.00 | GRIA1 (0.50) | GRIA1FOLH1CHRNDCHRNA1CHRNG | |
| SCHEMBL620471 | 1.00 | GRIA1 (0.50) | GRIA1FOLH1CHRNDCHRNA1CHRNG | |
| SCHEMBL28663068 | 1.00 | GRIA1 (0.50) | GRIA1FOLH1CHRNDCHRNA1CHRNG | |
| SCHEMBL8975007 | 1.00 | GRIA1 (0.50) | GRIA1FOLH1CHRNDCHRNA1CHRNG | |
| SCHEMBL23778217 | 1.00 | GRIA1 (0.50) | GRIA1FOLH1CHRNDCHRNA1CHRNG | |
| SCHEMBL28379862 | 1.00 | GRIA1 (0.50) | GRIA1FOLH1CHRNDCHRNA1CHRNG | |
| SCHEMBL38651117 | 1.00 | GRIA1 (0.50) | GRIA1FOLH1CHRNDCHRNA1CHRNG | |
| Hydrochloric Acid SCHEMBL906368 | 0.99 | GRIA1 (0.49) | GRIA1FOLH1CHRNDCHRNA1CHRNG | |
| Hydrochloric Acid SCHEMBL906366 | 0.99 | GRIA1 (0.49) | GRIA1FOLH1CHRNDCHRNA1CHRNG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6521594-B1 | Cyclic peptides which inhibit platelet aggregation without causing prolonged bleeding; high affinity for the receptor IIb/IIIa and a low affinity for the fibronectin and vitronectin receptors | LA JOLLA CANCER RESEARCH FOUNDATION | 2003-02-18 | — | — | US | disclosed |
| US-6395873-B1 | CYCLIC PEPTIDE; ANTICOAGULANT | LA JOLLA CANCER RESEARCH FOUNDATION | 2002-05-28 | — | — | US | disclosed |
| EP-0705274-B1 | METHOD AND COMPOSITION FOR TREATING THROMBOSIS | JOLLA CANCER RES FOUND (US) | 2000-08-30 | — | — | EP | disclosed |
| US-6017877-A | Method and composition for treating thrombosis | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 2000-01-25 | — | — | US | disclosed |
| EP-0873357-A2 | ANTITHROMBOTIC AGENTS AND METHODS OF USE | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1998-10-28 | — | — | EP | disclosed |
| US-5780303-A | Method and composition for treating thrombosis | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1998-07-14 | — | — | US | disclosed |
| US-5672585-A | HYDROPHOBIC AND CATIONIC AMINO ACID-CONTAINING CYCLIC (POLY)PEPTIDES HAVING HIGH AFFINITY FOR GLYCOPROTEIN IIB/IIIA RECEPTORS TO INHIBIT PLATELET AGGREGATION WITHOUT PROLONGED BLEEDING | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1997-09-30 | — | — | US | disclosed |
| WO-1997025343-A2 | ANTITHROMBOTIC AGENTS AND METHODS OF USE | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1997-07-17 | — | — | WO | disclosed |
| US-5612311-A | CYCLIC PEPTIDES | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1997-03-18 | — | — | US | disclosed |
| EP-0705274-A1 | METHOD AND COMPOSITION FOR TREATING THROMBOSIS | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1996-04-10 | — | — | EP | disclosed |
| WO-1995000544-A1 | METHOD AND COMPOSITION FOR TREATING THROMBOSIS | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1995-01-05 | — | — | WO | disclosed |